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Electrophysiologic effects of bretylium tosylate on trans-
membrane action potentials of canine Purkinje fibers
were studied by microelectrode methods. Perfusion of
this agent (20 mg/liter) prolonged the action potential
duration and the effective refractory period, but did not
alter the maximal diastolic potential, upstroke phase of
the action potential and membrane responsiveness curve
under normal oxygenation. With a hypoxic superfusion,
the action potential amplitude, maximal diastolic poten-
tial, maximal rate of depolarization and action potential
duration were all decreased. Subsequent addition of
bretylium antagonized all these effects of hypoxia and
restored the action potential variables to control values.
Bretylium tosylate is an antiarrhythmic agent that has both
a direct membrane action (1-5) and an indirect action, the
latter being exerted through an initial release of norepi-
nephrine from the sympathetic nerve endings and its sub-
sequent inhibition (6-8). This agent is often used with suc-
cess in thetreatment of ventricular tachyarrhythmias associated
with acute myocardial infarction, and appears to be partic-
ularly effective in those cases resistant to therapy using
"class I" antiarrhythmic agents (such as quinidine, pro-
cainamide and disopyramide) (9-12). Compared with the
relatively welldefined clinicalefficacy of bretylium, reports
on its mechanisms of action are not necessarily consistent
(1-5). Hence, in the present study, the electrophysiologic
effects of hypoxic perfusion on canine Purkinje fibers were
first observed, and then the effects of bretylium in this in
vitro model of myocardial infarction were studied by the
use of intracellular microelectrode techniques.
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However, similar effectsof hypoxia observed in Purkinje
fibers pretreated with reserpine were not reversed by
bretylium except for a prolongation of repolarization.
These results suggest that antiarrhythmic effects of
bretylium in hypoxic or depressed myocardium are
probably due to: 1) increased maximal rate of depolar-
ization (and conduction velocity) caused by membrane
hyperpolarization, and 2) prolongation of the effective
refractory period. The first electrophysiologic action ap-
pears to depend on catecholamine release by bretylium,
as hyperpolarization was not observed in reserpine-pre-
treated Purkinje fibers. The second effect may represent
a direct membrane action.
Methods
Experimental preparation. Adultmongrel dogs weigh-
ing 10 to 15 kg were anesthetized by intravenous injection
of pentobarbital sodium (30 mg/kg), The thorax was opened
and the heart quickly isolated. Purkinje fiber (false tendon)
preparations were dissected from either the right or left
ventricle, mounted in a 15 ml perfusion chamber and su-
perfused at a flow rate of 15 mllmin. The perfusate was a
modified Chenoweth 's solution with the following com-
position in millimoles/liter: sodium chloride (NaCI) , 119.8;
potassium chloride (KCI) , 4.5; calcium chloride (CaCI 2) ,
2.4; magnesium chloride (MgCI2) , 2.1; sodium bicarbonate
(NaHC0 3) , 25.0 and dextrose, 10,0, Its temperature was
maintained at 37 ± 1°C. The preparation was electrically
driven at a constant rate (cycle length 800 ms) through a
small bipolar silver electrode with an interpolar distance of
0.5 mm that was attached on one end of the false tendon.
The stimuli were square pulses of I to 5 ms duration and
twicethe threshold intensity generatedby an electronicstim-
ulator (Nihon Kohden MSE-40), and were applied through
an isolator. Transmembrane potentials were obtained using
glass microelectrodes filled with 3 M KCl, with resistances
of 10 to 30 megohms, amplified with a microelectrode am-
plifierand led into either a two to four channeloscilloscope
(Nihon Kohden VC-7A) or an eight channel storage oscil-
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Table 1. Sequential Changes in Po2, PC02 and pH of the Perfusate in Tissue Chamber During Control Period and Hypoxic Perfusion
Hypoxia Hypoxia Hypoxia Hypoxia
Control I (15 min) (30 min) (45 min) (60 min) Control II
P02(mm Hg) 550 ± 36 42 ± 7* 34 ± 9* 33 ± 5* 36 ± 5* 527 ± 19
PC02 (mm Hg) 33 ± 3 35 ± 4 36 ± 3 36 ± 3 36 ± 3 34 ± 4
pH 7.44 ± 0.07 7.46 ± 0.05 7.39 ± 0.04 7.40 ± 0.05 7.40 ± 0.05 7.42 ± 0.05
Data are based on six experiments. All measurements are expressed as mean values ± standard deviation ,
* = statistical significance at 0.1% level compared with control I values.
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Figure1. Representative records showing theeffects of bretylium
tosylate on the action potential and effective refractory period of
the Purkinje fiber. The upper panel shows the action potential
(mV) (top) and the maximal rate of depolarization (Vis) (bottom)
of the basic (left) and premature (right) responses during control
perfusion. The lower panel shows similar records obtained after
30 minutes of perfusion of bretylium (20 mg/liter).
preparations (group 3 experiment). The animals received
0.5 mg/kg of reserpine (Dai-ichi PharmaceuticalCompany)
intraperitoneally for 2 days, and were sacrificedon the third
day.
Statistical analysis. Results were based on those ex-
periments in which microelectrode impalement of the same
single Purkinje fiber was maintained throughout the pro-
cedure. When the level of direct current of the membrane
loscope (Sony-Tektronix R-5113). The upstroke of the ac-
tion potential was differentiated with an operational ampli-
fier having a time constant of 10 J-Ls. The action potential
and its first derivative were photographed on oscillopaper
or Polaroid film.
Normoxic and hypoxic perfusion. The partial pressure
of oxygen (Po2) , partial pressure of carbon dioxide (PC02)
and pH of the perfusate in the tissue chamber were contin-
uously monitored with the use of an automatic pH blood
gas system (Coming 175). During normoxicperfusion (with
the perfusate being saturated with 95% oxygen [02] + 5%
carbon dioxide [C02]), the P02 was 550 ± 36 mm Hg
(Table I), whereas the P02 after 3 minutes of hypoxic
perfusion (perfusate saturated with 95% nitrogen [N2] +
5% CO2) measured 34 ± 9 mm Hg. The Pee, and pH
remained essentially unchanged under these two perfusion
conditions (Table I), and hence, electrophysiologic changes
observed during the hypoxic perfusion were thought to de-
pend solely on the lowered oxygen pressure.
Electrophysiologic measurements. The effects of bre-
tylium tosylate (Burroughs WellcomeCompany)were stud-
ied under normal (group I experiment) and lowered (group
2 experiment) oxygen pressure. Under both conditions, the
concentration used was 20 mg/liter, and the perfusion was
maintained for 30 minutes. In addition to the effects of
bretylium on the action potential configuration, its effects
on the effective refractory period and membrane respon-
siveness curve were studied in the presence of normal ox-
ygenation. Whenstudying the refractoryperiod, a premature
stimulus of four times the threshold intensity was applied
after every 10 basic stimuli, initially early in phase 3 of the
preceding action potential so that no response was evoked.
The coupling intervalof the premature stimuliwasgradually
increased in steps of 2 to 5 ms until the Purkinje fiber
respondedwith an action potential showinga rapid upstroke.
The shortest coupling interval producing such a response
was used as the effective refractory period. The membrane
responsiveness curve was obtained by correlating the max-
imal rateof depolarizationwith the level of take-offpotential
when the membrane was depolarized by an increase in the
potassium concentration of the perfusate from 4.5 to 18.0
roM. To rule out the effects of intrinsic catecholamine,
experiments were carried out using reserpine-pretreated
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Table 2. Summary of Bretylium Effects on Various Electrophysiologic Variable, of Purkinje Fibers Bm,ed on Eight Experiments
Control Brctyhurn Washout
APA (rnv) 123,I ± 38 123.7 ± 47 124.0 ± 3.7
MDP ( ~mV) 89.1 ± 2 0 89.5 ± I 2 88.9 ± 08
OS (mV) 343 ± 4.2 344 ± 5 I 353 ± 3.9
MRD (Vis) 5306 ± 66.4 526.2 ± 699 532.3 ± 55 9
APD50 (ms) 219.8 ± 183 2490 ± 23.8* 255.0 ± 16.4*
APDoo (ms) 296.0 ± II 2 342.0 ± 11.2t 341.8 ± 107*
EP (ms) 280.0 ± II 7 3218±126t 323.5 ± 185'
TOP (-mV) 71.6 ± 7.6 70.1 ± 8.1 70.5 ± 84
All measurements are expressed as mean value, ± standard deviation * and t = staustical significance at I 0 and 0 I '7c levels, respectively, as
compared with control values.
APA = action potential amplitude; APD50 and APDoo = action potential duration at 50 and 90'7c of repolanzanon, respectively; ERP = effective
refractory period; MDP = maximal diastolic potential, MD = maximal rate of depolanzanon, OS = overshoot: TOP = take-off potential of the
earliest premature response obtained dunng the determination of effective refractory penod
potential at the end of the experiment shifted by more than
3 mV compared with the initial value, the experiment was
excluded, Thus, the numbers of successful experiments in
individual groups were 8 of 20 in group I, 6 of 32 in group
2 and 8 of 28 in group 3, In the statistical analysis of various
measurements, Student's paired t test was used, and the
change was considered significant when the probability [p]
value was less than 0,05.
Results
Effects of bretylium under normoxic perfusion. The
Purkinje fiber preparation was superfused under conditions
of normal oxygen concentration for 30 to 60 minutes. Bre-
tyium was then added to the perfusate, and its effects on
the action potential characteristics were studied. The rep-
resentative records in Figure I suggest that bretylium does
not affect the level of diastolic membrane potential or the
depolarization phase of the action potential, but prolongs
the repolarization phase. When the results of eight such
experiments were summarized, the action potential duration
at 50 and 90% of repolarization and the effective refractory
period were all prolonged to a similar extent. or by 13.3.
15.5 and 14.9%. respectively (Table 2). The take-off po-
tential of the earliest premature response during the deter-
mination of effective refractory period was essentially un-
changed from the control value (-71.6 mY). Even after
60 minutes of washout of this agent with the control per-
fusate, the action potential duration and the effective re-
fractory period did not return to the initial control level.
When grouping the eight experiments together, it was
found that bretylium did not Significantly alter the action
potential amplitude, the maximal diastolic potential and the
maximal rate of depolarization (Table 2). When individual
experiments were studied, however, four showed an in-
crease in the maximal diastolic potential after the addition
of bretylium, whereas in the remaining four experiments.
this value either remained unchanged or decreased (Fig. 2).
Because the former four cases had initial diastolic potentials
less negative than - 88 mV, whereas the latter four cases
had diastolic potentials of - 90 mV or more, bretylium
appeared to hyperpolarize those fibers showing slightly de-
creased membrane potentials.
Membrane responsiveness curves were obtained before
and after the addition of bretylium in four preparations. In
one preparation (Fig. 3) the take-off potential was - 87.3
mV and the maximal rate of depolarization was 585 Vis at
the K ~ concentration of 4.5 mM during the control perfu-
sion, whereas after 30 minutes ofbretylium perfusion, these
measurements were increased to - 90 mV and 597 VIs,
respectively, at the same K + concentration. However, the
curves obtained under these two perfusion conditions were
almost precisely superimposed, indicating that this agent
did not affect membrane responsiveness.
Effects of bretylium under hypoxic perfusion. To study
the electrophysiologic interactions of bretylium and lowered
oxygen concentrations, the effects of hypoxic perfusion alone
on Purkinje fibers were determined first. Subsequently, bre-
tylium was added to the perfusate in the presence of hypoxia,
and changes in the action potential characteristics were ob-
served. Representative action potential records are shown
in Figure 4, and the data from six such experiments are
summarized in Figure 5. When the perfusate was made
hypoxic for 60 minutes after 30 to 60 minutes of normoxic
(control) perfusion, the action potential amplitude and the
maximal diastolic potential were decreased. However, these
changes were not uniformly progressive. The maximal di-
astolic potential, for instance, showed a diphasic change,
with an initial decrease from - 91.0 to - 86.5 mV after 20
minutes of hypoxic perfusion (-4.9%, P < 0.005), fol-
lowed by a slight increase to - 88.6 mV after 30 minutes.
This measurement did not change further, showing a value
of - 88.6 mV after 60 minutes of hypoxia. These two values
at 30 and 60 minutes were significantly lower than the initial
control values (p < 0.01 and p < 0.05, respectively).
The maximal rate of depolarization was also decreased
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Figure 2. Effects of bretylium on the maximal diastolic potential
(MOP) in eight individual preparations.
rate of depolarization was further decreased to 489.7 Vis,
thus showing a triphasic response. This latter value corre-
sponded to a 5.2% decrease (p < 0.01) compared with the
control value, and was significantly lower (p < 0.005) even
compared with the value at 30 minutes of hypoxia. On the
other hand, the action potential duration at 50 and 90% of
repolarization showed a progressive shortening. After 30
minutes of hypoxic perfusion, the former was decreased
from 222.4 to 179.7 ms (-19.2%, P < 0.001) and the
latter from 288.7 to 262.8 ms (-9.0%, p < 0.001). These
measurements were further decreased after 60 minutes of
hypoxia, with the 50% action potential duration reaching
174.0 ms ( - 21.8% compared with the control value, p <
0.001) and the 90% action potential duration reaching 257.8
ms (-10.7%, P < 0.001). However, these values were not
significantly lower than those attained after 30 minutes of
hypoxic perfusion. Hence, perfusion with a lowered oxygen
concentration shortened the repolarization (especially the
plateau) phase of the Purkinje action potential, but this effect
appeared to stabilize after 30 minutes as did the changes in
the action potential amplitudeand maximaldiastolicpotential.
On a return to the normal oxygen concentration, these
electrophysiologic effects of hypoxia dissipated within 10
to 20 minutes, and the action potential measurements re-
turned to the control levels (Fig. 5, control II). When hy-
poxia was started again after 30 minutes of normoxic per-
fusion, the action potential amplitude, maximal diastolic
potential and maximal rate of depolarization decreased with
either diphasic or triphasic pattern, in much the same manner
as was observed during the first hypoxic period. The sec-
ondary increase in these measurements after their initial
decrease, however, occurred after 10 minutes in the second
period of hypoxic perfusion, compared with 20 minutes in
the first period of hypoxic perfusion. The shortening of the
action potential duration again progressed in a monophasic
fashion.
When bretylium was added to the perfusate in the latter
halfof60 minutes ofthis second hypoxia, the action potential
amplitude and maximal diastolic potential were significantly
increased (n = 6). Namely, after 30 minutes of bretylium
perfusion, the action potential amplitude increased from
122.3 to 125.5 mV or by 2.6% (p < 0.005), and the maximal
diastolic potential from - 88.5 to - 90.2 mV or by 1.9%
(p < 0.05). The maximal rate of depolarization tended to
increase with bretylium perfusion, attaining values of 507.0,
511.6 and 507.7 Vis after 10, 20 and 30 minutes, respec-
tively. As the time course of such an increase was not
identical in individual preparations, these values were not
significantly different from those immediately before the
addition of bretylium and after 30 minutes of hypoxic per-
fusion alone (493.5 Vis). However, when the second hy-
poxic perfusion was maintained for 60 minutes without add-
ing bretylium in three other experiments not included in
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from the control value of 516.3 to 487.5 Vis or by 5.6%
(p < 0.001) after 20 minutes of hypoxic perfusion. This
measurement was increased to 497.7 VIs after 30 minutes,
although this value was still 3.6% lower than the control
value (p < 0.05). After 60 minutes of hypoxia, the maximal
Figure 3. Effects of bretylium on the membrane responsiveness
curve. MP = levels of membrane potential from which action
potentials were fired (take-off potential) and MRO = maximal
rate of depolarization. Note complete superposition of the curve
during the control period and after bretylium perfusion.
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Figure 4. Sequential records showing the effects
of hypoxic perfusion alone (upper panels) and the
effects of hypoxia plus bretylium (lower panels) in
a nonreserpinizedPurkinje preparation. In each panel,
the action potential (mV) with zero reference po-
tential (top) and the maximal rate of depolarization
(Vis) (bottom) arc shown. Records marked Control
II were obtained after 30 minutes of perfusion with
normal oxygenation following an initial 60 minutes
of hypoxic perfusion. Records marked Hypoxia 60'
and Bretylium 3D' were obtained at the end of the
second hypoxic period during the last 30 minutes
of which bretylium was added to the perfusate .
Figure 5, the maximal rate of depolarization was further
decreased during the last 30 minutes, whereas other vari-
ables either remained unchanged or decreased slightly. Hence.
it is suggested that I) the second period of hypoxia quali-
tatively reproduced the effects of the first hypoxic perfusion,
and 2) the tendency of the maximal rate of depolarization
to increase on bretylium perfusion, although insignificant
as compared with the value immediately before the addition
of this agent , would imply a reversal of the expected de-
crease of this measurement after 60 minutes of hypoxia.
Regarding the effects on the repolarization phase, bre-
tylium prolonged the action potential duration at 50% of
repolarization from 18104to 210.2 ms ( + 15.9%, P < 0.01) ,
and at 90% of repolar ization the duration was prolonged
from 264.0 to 316.5 ms (+ 19.9%, P < 0.001) , respec-
tively, in the presence of lowered oxygen concentration.
These results indicate that bretylium antagonized all the
electrophysiologic effects of hypoxia and tended to restore
various action potential measurements toward normal levels.
Effects of bretylium on Purkinje preparations treated
with reserpine. To determine whether the hyperpolariza-
tion caused by bretylium in the presence of hypoxia de-
pended on its direct membrane action or catecholamine re-
lease from the sympathetic nerve endings, similar experiments
were carried out using reserpine-pretreated Purkinje prep-
arations. Representative records are shown in Figure 6, and
the data from eight experiments are summarized in Figure
7. As seen in the left half of Figure 7, the effects of hypoxic
perfusion in reserpinized preparations were qualitativel y al-
most identical to those observed in nonreserpinized prepa-
rations. When bretylium was added to the perfusate in the
last 30 minutes of the second hypoxic period , the action
potential amplitude and the maximal diastolic potential re-
mained unchanged. The maximal rate of depolarization de-
creased from 514.8 to 499.7 Vis or by 3.0% (p < 0.05 ).
Bretylium perfusion significantly prolonged the action po-
tential duration at 50% ofrepolarization from 162.8 to 194.0
ms or by 19.2% (p < 0.005) , and at 90% of repolarization
from 240.8 to 290.5 ms or by 20.6% (p < 0.005) .
Discussion
Experimental model of ischemia and hypoxia.
Electrophysiologic effects of various antiarrhythmic agents
are commonly studied with microelectrode techniques, us-
ing normal myocard ial preparation s perfused under physi-
ologic conditions. However, it is quite likely that various
rhythm disturbances tend to arise from abnormal cardiac
tissue , and hence, precise mechanisms of action of those
antiarrhythmic agents may not be identified in experiments
using only normal myocardium. Because bretylium has a
major indication in ventricular tachyarrhythmias associated
with acute myocardial infarction (10), elucidation of its
electrophysiologic action in an ischemic tissue is definitely
desirable. Unfortunately , from a technical standpoint the
application of intracellular microelectrode techniques in in
situ hearts is quite difficult. To circumvent this problem,
Purkinje fiber-ventricular muscle preparations are often dis-
sected from the region of experimentally produced myo-
cardial infarction and perfused in a tissue bath. However,
this method is subject to the following criticisms: I) in-
farcted ventricular tissues superfused under a normal oxygen
concentration cannot be regarded as a good experimental
model of ischemic myocardium . and 2) according to an
earlier report, superfusion of such a preparation rapidly im-
proved the action potential upstroke from a slow response
to an almost normal level within two hours, whereas , the
action potential duration continued to be prolonged even
after 14 hours and failed to reach a steady state (13). This
behavior in similar preparations almost precludes a precise
evaluation of drug effects, particularly on refractoriness.
One other method utilizes perfusion of normal cardiac
tissue under abnormal conditions, such as hypoxia . to sim-
ulate myocardial ischemia . In the present experiment when
the perfusate was made hypoxic for the second time , after
reinstitution of normal oxygenation for 30 minutes, changes
in the action potential characteristics observed during the
initial period of hypoxic perfusion were very well repro-
duced (Fig. 5 and 7). Hence, this experimental model ap-
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Figure 5. Statistical analyses of sequential changes
in various action potential characteristics produced
by hypoxia and bretylium perfusion, based on six
experiments using nonreserpinized preparation. Open
circles with vertical bars represent mean values ±
standard deviation. Asterisks indicate that the values
are significantly different (at 5% level) from either
Control I or Control II measurements. Probability
values with brackets denote statistical significance on
comparing individual measurements after 30 minutes
of hypoxia with those after 60 minutes of hypoxia.
NS = not significant; other abbreviations as in Table
2.
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Figure 6. Sequential records showing the effects
of hypoxic perfusion alone (upper panels) and hy-
poxia plus bretylium (lower panels) on action po-
tential configuration and maximal rate of depolar-
ization in a Purkinje preparation pretreated with
reserpine. See Figure 4 for detailed explanation.,~]
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Figure 7. Statistical analyses of sequential changes
in various action potential characteristics produced
by hypoxia and bretylium perfusion, based on eight
experiments using preparations treated with reser-
pine. See Figure 5 for detailed explanation. Abbre-
viations as in Table 2.
MRD
(Vis)
SOO
450
3S0
APD 300
90
250
APD so
200
(ms)
150
60 min
WashoutI
ler.tylil.lTli
I Hypoxia n
+~~~-;;:::;::--'
Control II
I Hypoxia I
+ ;
Control I
peared suitable for assessing the electrophysiolo gic effects
of antiarrhythmic agents . Although, in add ition to hypoxia ,
acidosis and an increa sed extracellular K + concentration are
said to be present in the infarcted myocardium, hypoxic
perfusion alone was used in the present study. It is important
to note that in the clinical setting of acute myocardial in-
farction , the ischemic area is heterogeneous in terms of fiber
types and the degree of pathophysiologic changes, whereas
the present experimental preparation used uniformly hy-
poxic Purkinje fibers alone. Hence , this model has certa in
limitations in simulating clini cally encountered myocardial
ischem ia. However, it has often been suggested that a " bor-
der zone" located between totally ischemic and normal tis-
sues may become the site of ectopi c impulse formation . The
preparation used in our study may simulate such an inter-
mediately ischemic area, where partially depressed fast Na +
current contributes to a slow conduction and perhaps reentry.
Effects of bretylium on normal Purkinje fibers. The
first finding of note in the present study is that in the presence
of normal oxygenation, bretylium did not significantly affect
the action potential amplitude, maximal diastolic potenti al
and maximal rate of depolarization , but prolonged action
potenti al duration and effective refractory period. These
results appeared to reconfirm previous reports (1 ,2 ,5). In
two of these earlier report s, howe ver , bretylium was said
to shift the membrane responsiveness curv e toward more
negative membrane potential level s. In contrast , the lack of
change in membrane responsiveness in the present study
would suggest that bretylium affected neither the conduct-
ance of the fast Na + current nor the inacti vation parameter
" h" at individual membrane potent ial levels. This discrep-
ancy can probably be ascribed to the difference in the method
used . We studied membrane responsiveness in the steady
state by depolarizing the membrane with an increased K +
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concentration (18.0 mM). On the other hand, the previous
investigators (1,2) used premature stimulation during phase
3 of repolarization to fire the Purkinje fiber at various levels
of membrane potential.
Time course of the effects of hypoxia on Purkinje
fibers. Our second finding was that currently observed elec-
trophysiologic effects of hypoxia on Purkinje fibers were
also similar to those reported by other investigators (14-
16). However, those earlier reports did not systematically
study sequential changes in the action potential character-
istics. In our study, the maximal diastolic potential and the
maximal rate of depolarization were rapidly decreased after
the start of hypoxic perfusion probably because of an in-
hibition of sodium-potassium (Na-K) pump, attaining min-
imal values at 20 minutes. These variables were somewhat
increased from 20 to 30 minutes, despite persistence of
lowered oxygen concentration. During the following 30
minutes of hypoxic perfusion, the maximal diastolic poten-
tial showed no further change, whereas the maximal rate of
depolarization gradually decreased again. One might argue
that as the changes in these values are rather small, they
may merely reflect random, small variations in those action
potential variables. However, the observed changes were
quite uniform in individual experiments and not at all ran-
dom, which explains the statistically highly significant dif-
ferences. Hence, these alterations must necessarily represent
the effects of hypoxia or bretylium.
Regarding the physiologic or pharmacologic importance
of these observations, the changes in various measurements
may not appear great enough to be of clinical significance.
It is, however, also true that only a small change in an
electrophysiologic variable may be sufficient to abolish a
reentrant movement. Nevertheless, the time course of elec-
trophysiologic changes described is quite similar to that of
adenosine triphosphate (ATP) efflux observed during hy-
poxic perfusion of isolated rabbit hearts (17), giving us
certain insights into their mechanisms. The slight improve-
ment in the action potential characteristics observed after
20 minutes of hypoxic perfusion may well reflect an in-
creased ATP production through anaerobic glycolysis.
Mechanisms of hyperpolarization by bretylium. The
third major finding in the present study is that bretylium
increased action potential amplitude, maximal diastolic po-
tential and maximal rate of depolarization in the presence
of hypoxia. Here again, we feel that the changes are small
but clinically significant, because further reductions in those
variables expected in the last 30 minutes of the second
hypoxic period were actually reversed by this agent. A sim-
ilar observation was previously reported by Cardinal and
Sasyniuk (5), but some of the problems inherent to their
experimental model (or an infarcted myocardium perfused
under normal oxygenation) were pointed out earlier. Bre-
tylium appeared to show a similar action even in the pres-
ence of normal oxygen concentration when the membrane
potential was somewhat decreased initially. Because the
membrane responsiveness curve was not altered by bre-
tylium (Fig. 3), the bretylium-induced increase in the max-
imal rate of depolarization is considered to result from hy-
perpolarization of the cell membrane. Furthermore, the fail-
ure of bretylium to show this action in preparations pretreated
with reserpine would suggest that this agent hyperpolarizes
the membrane through the release of norepinephrine from
sympathetic nerve endings.
Such norepinephrine-induced hyperpolarization in the
hypoxic myocardium is probably caused by I) an increase
in the steady-state K+ conductance (18), and 2) an increase
in ATP production and the Na-K pump activity secondary
to an acceleration of glucose transport into the cell and of
the glycolytic process (19). Indeed, catecholamine has been
shown to hyperpolarize Purkinje fibers with a lowered mem-
brane potential (20). Watanabe et al. (3), on the other hand,
observed a similar hyperpolarizing effect of bretylium in
rabbit ventricular fibers regardless of their membrane po-
tential levels. Whether this discrepancy can be explained
by the species difference alone is unknown.
Mechanisms of prolonged repolarization by bretyl-
ium. The fourth notable finding is that bretylium signifi-
cantly prolonged the action potential duration (and the
effective refractory period) irrespective of the oxygen con-
centration and the presence or absence of reserpinization.
Therefore, this change must represent the direct membrane
action of this agent. The report that a high concentration of
bretylium (50 mg/liter) increased myocardial contractility,
even in the presence of 10- 4 M propranolol (21), would
suggest an increase in the slow inward current and Ca + +
influx (caused by a direct membrane action) as the mech-
anism for the prolonged plateau or the action potential du-
ration at 50% of repolarization. Markis and Koch-Weser
(22) reported that the positive inotropic effect of bretylium
was abolished by 10- 6 M propranolol. Hence, the role of
norepinephrine-releasing action of bretylium in increasing
myocardial contractility may not be ruled out. The effect
of bretylium on ix', another ionic current contributing to
repolarization, should be studied with voltage clamp tech-
niques.
Possible antiarrhythmic mechanisms of bretylium.
Finally, the efficacy of bretylium for ventricular tachyar-
rhythmias associated with ischemic heart disease should also
be discussed. In the presence of ischemia, decreased con-
duction due to partial depolarization of the cell membrane
and shortening of refractory period due to accelerated re-
polarizationwould facilitatereentrantmovements, thus leading
to the production of premature systoles, paroxysmal tachy-
cardia and ventricular fibrillation. Possible improvement of
conduction secondary to hyperpolarization and prolongation
of refractory period caused by bretylium would reverse all
the electrophysiologic effects of ischemia, and appears to
provide the most ideal combination of events in abolishing
reentrant movements.
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On the other hand, bretylium was also shown to be ef-
fective in the treatment of ventricular tachycardia caused by
quinidine toxicity (23). Conceivable mechanisms of such
an action would include bretylium-induced hyperpolariza-
tion antagonizing partial depolarization of membrane by
quinidine. In addition, it is possible that bretylium also
antagonized the prolongation of the action potential duration
caused by quinidine, as had been reported by de Azevedo
et al. (4). The observation by these authors (4) of accelerated
repolarization in rabbit ventricular muscle fibers is, how-
ever, at variance with the present study showing prolonged
action potential duration in canine Purkinje fibers . But again,
the importance of species differences may have to be con-
sidered. Furthermore, if the hyperpolarizing effect of bre-
tylium is solely dependent on catecholamine release, the
question must be answered about the duration of such an
action in the clinical setting because of the expected later
inhibition of norepinephrine by bretylium.
Nevertheless. bretylium is one of a few pharmacologic
agents that improve conduction and it occupies a unique
position in antiarrhythmic therapy. It must then be reem-
phasized that, because of this action, I) bretylium should
not be used concomitantly with the class I antiarrhythmic
agents that depress conduction (for example, quinidine, pro-
cainamide and disopyramide), and 2) it is worth trying this
agent to treat those arrhythmias resistant to other commonly
used antiarrhythmic agents, especially in the presence of
ischemic heart disease.
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